Octopus Investments is launching a £20m joint fundraising for two alternative investment market (AIM) VCTs.
The team - a part of Octopus Group - already runs several VCTs, including some AIM-dedicated ones. These new products would be made up of 90 companies, investing across a variety of sectors, including pharmaceuticals, biotech, healthcare services, software development and clean energy tech. The fundraising will allow investors access to Octopus AIM VCT plc (AIM VCT) and Octopus AIM VCT 2 plc (AIM VCT 2), which both target a 5% tax-free dividend yield every year. VCTs can enable investors to receive 30% income tax relief (as long as the shares are held for at least five years), tax fre...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
